N

NEWTON BIOCAPITAL

19 employees

Newton Biocapital is a venture capital investment fund that invests in the life sciences sector with a specialization in chronic diseases.

Investor insights

Sectors invested in

Biotechnology6
Medical6
Medical Device4
Health Care4
Pharmaceutical3
Deuterated small molecules2
Drug Development2
MET kinase inhibitor2
Malnutrition1
Life Science1
Therapeutics1
Manufacturing1
Clinical nutrition1
Medical Devices1
Homecare1
ICT1
Intensive Care1
Liver disease1
Fluid overload1
Heart Failure1

Funding rounds participated in

$7.7M sweet spot round size

Most of their 13 investments are in rounds between $4.7M and $9.8M

Investor type

Micro VC

Basic info

Industry

venture capital and private equity principals

Sectors

Financial Services
Finance
Venture Capital

Date founded

2017

Investments made

S

Santero Therapeutics raised $8.6M on June 8, 2023

Investors: -, SFPI-FPIM, SRIW and NEWTON BIOCAPITAL

A

AdipoPharma raised undisclosed on January 23, 2023

Investors: Good Growth Capital and NEWTON BIOCAPITAL

D

DeuterOncology NV raised $6.2M on January 19, 2023

Investors: -, INVESTSUD (Capital & Croissance) and NEWTON BIOCAPITAL

N

NeuVasQ Biotechnologies raised $24M on June 24, 2021

Investors: NEWTON BIOCAPITAL

U

Undisclosed raised $7.4M on May 26, 2021

Investors: Global Brain Corporation and NEWTON BIOCAPITAL

D

DeuterOncology NV raised undisclosed on February 24, 2021

Investors: NEWTON BIOCAPITAL

U

Undisclosed raised $1.3M on November 30, 2020

Investors: NEWTON BIOCAPITAL

U

Undisclosed raised $16K on July 30, 2020

Investors: 大原薬品工業（株）, NVCC and NEWTON BIOCAPITAL

U

Undisclosed raised $7.7M on March 1, 2019

Investors: Japan Science & Technology Agency (JST) and NEWTON BIOCAPITAL

S

Sequana Medical AG raised $9.8M on October 16, 2018

Investors: SFPI-FPIM and NEWTON BIOCAPITAL

FAQ